ONCIN — Oncoinvent ASA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Oncoinvent ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	NAS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	113	292	196	32.1	136
Net Total Accounts Receivable
Net Total Receivables	12.6	15.1	16.7	25.8	8.61
Total Other Current Assets
Total Current Assets	126	307	213	57.9	144
Net Property, Plant And Equipment	13	23.9	21.4	40.8	26.7
Other Long Term Assets
Total Assets	139	331	234	98.7	171
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13	23	31.5	35.5	57.9
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	13	33.7	40.3	43.8	62.7
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	126	297	194	54.9	108
Total Liabilities & Shareholders' Equity	139	331	234	98.7	171
Total Common Shares Outstanding